October 22, 2016 1:16 AM ET


Company Overview of SCILEX Pharmaceuticals, Inc.

Executive Profile

Philip P. Gerbino Ph.D.

Strategic Advisor, SCILEX Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 11 Board Members in 11 different organizations across 6 different industries.

See Board Relationships


Dr. Philip P. Gerbino, Ph.D., has been Strategic Advisor of SCILEX Pharmaceuticals, Inc. since June 2015. Dr. Gerbino has been the the President of Arrow Prescription University of the Centers, Health ATOZ Sciences, (School of Pharmacy) since 1995. Dr. Gerbino is a Civilian Consultant for pharmacy to the Air Force Surgeon General. He serves as a Consultant in strategic planning and marketing and new business development to pharmaceutical companies and health care industries. ...

Corporate Headquarters

301 Lindenwood Drive
Malvern, Pennsylvania 19355

United States

Phone: 610-644-5352
Fax: 610-644-5358

Board Members Memberships

Director, Member of Audit Committee and Member of Special Committee of Independent Directors
Director, Chairman of Nominating and Governance Committee and Member of Audit and Compliance Committee
Director, Member of Audit Committee and Member of Nominating & Governance Committee


University of the Sciences In Philadelphia
University of the Sciences In Philadelphia

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact SCILEX Pharmaceuticals, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.